Nationwide coverage and cost-sharing for PCSK9 inhibitors among Medicare Part D plans

Dhruv S. Kazi, Christine Y. Lu, Grace A. Lin, Colette DeJong, R. Adams Dudley, Randi Chen, Chien Wen Tseng

Research output: Contribution to journalArticlepeer-review

15 Scopus citations
Original languageEnglish (US)
Pages (from-to)1164-1166
Number of pages3
JournalJAMA cardiology
Issue number10
StatePublished - Oct 2017
Externally publishedYes

Bibliographical note

Funding Information:
Conflict of Interest Disclosures: All authors have completed and submitted the ICMJE Form for Disclosure of Potential Conflicts of Interest and none were reported. Funding/Support: This study was funded by grant R03HS016772 from the Agency for Healthcare Research and Quality and the Hawaii Medical Services Association Endowed Chair in Health Services and Quality Research. Role of the Funder/Sponsor: The funders had no role in the design and conduct of the study; collection, management, analysis, and interpretation of the data; preparation, review, or approval of the manuscript; and decision to submit the manuscript for publication. Disclaimer: Dr Chien-Wen Tseng is a member of the US Preventive Services Task Force. This article is the original work of its authors and does not represent the position or recommendation of the US Preventive Services Task Force.

Cite this